Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Amgen, Immunex deal

AMGN completed its previously announced acquisition of IMNX last Tuesday. The purchase price

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE